Pulmonology
Page 1 • 3 itemsGain critical insights into global pulmonology drug development, clinical trials, regulatory approvals, and market trends for strategic pharma investment.
Rein Therapeutics LTI-03 Phase 2 Trial Enrolls 8 Patients for Idiopathic Pulmonary Fibrosis Treatment
Rein Therapeutics reports 8 patients enrolled in Phase 2 RENEW study of LTI-03 for idiopathic pulmonary fibrosis across US, Australia, and Poland sites.
AstraZeneca's BREZTRI Aerosphere Approved as First Triple Therapy for Asthma in Patients 12 and Older
AstraZeneca receives FDA approval for BREZTRI Aerosphere as the first and only triple-combination therapy for asthma maintenance treatment in patients aged 12+.
Tozorakimab Meets Primary Endpoint in Phase III COPD Trial, Shows Significant Reduction in Exacerbations
First-in-class tozorakimab demonstrates statistically significant reduction in COPD exacerbations across all patient populations in pivotal Phase III MIRANDA trial.